Regular paperAntinociceptive effects of the selective non-peptidic δ-opioid receptor agonist TAN-67 in diabetic mice
References (18)
- et al.
Paradoxical analgesia produced by naloxone in diabetic mice is attributable to supersensitivity of δ-opioid receptors
Brain Res.
(1992) - et al.
Effects of diabetes on stress-induced analgesia in mice
Brain Res.
(1992) - et al.
Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ-and κ-opioid agonists
Brain Res.
(1992) - et al.
Effect of diabetes on the antitussive effect of β-endorphin
Brain Res.
(1993) - et al.
Streptozotocin-induced diabetes selectively reduces antinociception mediated by μ1-opioid receptors, but not that mediated by μ2-opioid receptors
Neurosci. Lett.
(1994) - et al.
Streptozotocin-induced diabetes selectively enhances antinociception mediated by δ1- but not δ2-opioid receptors
Life Sci.
(1994) - et al.
A highly selective δ1-opioid receptor antagonist: 7-benzylidenenaltrexone
Eur. J. Pharmacol.
(1992) - et al.
Crosstolerance studies in the spinal cord of β-FNA-treated mice provides further evidence for delta opioid receptor subtypes
Life Sci.
(1991) - et al.
A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86
J. Pharmacol. Exp. Ther.
(1993)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 1995 Published by Elsevier B.V.